Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effects of Remimazolam on Postoperative Myocardial Injury
Sponsor: Affiliated Hospital of Jiaxing University
Summary
This study is designed as a prospective, double-blind, randomized controlled trial to investigate the effect of remimazolam on intraoperative cardiac output (CO) in elderly patients undergoing general anesthesia, and to evaluate its protective efficacy against elevated high-sensitivity cardiac troponin T (hs-cTnT) levels and perioperative myocardial injury.
Official title: Effects of Remimazolam and Propofol on Postoperative Myocardial Injury in Elderly Patients Undergoing General Anesthesia
Key Details
Gender
All
Age Range
65 Years - Any
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-08-01
Completion Date
2029-06-01
Last Updated
2026-08-25
Healthy Volunteers
No
Conditions
Interventions
Remimazolam
Induction dose of remimazolam: 0.2-0.4 mg/kg; maintenance dose of remimazolam: 0.2-1 mg/kg/h. Maintain BIS values between 40 and 60.
Propofol
Induction dose of propofol : 1.5 -2.5mg/kg; maintenance dose of propofol : 1.5-4.5mg/kg/h. Maintain BIS values between 40 and 60.
Locations (1)
Jiaxing University Affiliated Hospital
Jiaxing, Zhejiang, China